--- title: "12 Health Care Stocks Moving In Tuesday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/286948585.md" description: "On Tuesday, Med Pharmaceuticals (NASDAQ:INM) saw a 127% increase to $1.54, while MetaVia (NASDAQ:MTVA) rose 58.54% to $1.76. Other gainers included Co-Diagnostics (NASDAQ:CODX) up 41.6% and Edesa Biotech (NASDAQ:EDSA) up 32.11%. Conversely, WORK Medical Tech Gr (NASDAQ:WOK) dropped 39% to $0.23, and Autonomix Medical (NASDAQ:AMIX) fell 25.43%. AIM ImmunoTech (AMEX:AIM) declined 18.02% to $0.33." datetime: "2026-05-19T17:06:30.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286948585.md) - [en](https://longbridge.com/en/news/286948585.md) - [zh-HK](https://longbridge.com/zh-HK/news/286948585.md) --- # 12 Health Care Stocks Moving In Tuesday's Intraday Session ### Gainers - **InMed Pharmaceuticals** (NASDAQ:INM) shares increased by 127.0% to $1.54 during Tuesday's regular session. The company's market cap stands at $2.2 million. - **MetaVia** (NASDAQ:MTVA) shares moved upwards by 58.54% to $1.76. The market value of their outstanding shares is at $5.7 million. The company's, Q1 earnings came out 3 days ago. - **Co-Diagnostics** (NASDAQ:CODX) stock increased by 41.6% to $1.94. The company's market cap stands at $4.9 million. As per the press release, Q1 earnings came out 3 days ago. - **Edesa Biotech** (NASDAQ:EDSA) shares moved upwards by 32.11% to $11.89. The market value of their outstanding shares is at $75.1 million. As per the press release, Q2 earnings came out 3 days ago. - **Adial Pharmaceuticals** (NASDAQ:ADIL) stock moved upwards by 29.5% to $2.08. The market value of their outstanding shares is at $3.4 million. - **Virax Biolabs Group** (NASDAQ:VRAX) stock moved upwards by 26.55% to $0.3. The company's market cap stands at $1.7 million. ### Losers - **WORK Medical Tech Gr** (NASDAQ:WOK) stock decreased by 39.0% to $0.23 during Tuesday's regular session. - **Autonomix Medical** (NASDAQ:AMIX) shares fell 25.43% to $0.23. The market value of their outstanding shares is at $3.5 million. - **AIM ImmunoTech** (AMEX:AIM) shares declined by 18.02% to $0.33. The company's market cap stands at $6.3 million. As per the news, the Q1 earnings report came out 2 days ago. - **Akanda** (NASDAQ:AKAN) shares fell 17.18% to $13.5. The company's market cap stands at $8.7 million. - **Psyence Biomedical** (NASDAQ:PBM) shares fell 16.82% to $3.83. The company's market cap stands at $4.7 million. - **Quantum Cyber** (NASDAQ:QUCY) stock fell 16.67% to $2.75. The market value of their outstanding shares is at $41.3 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md) - [WOK.US](https://longbridge.com/en/quote/WOK.US.md) - [MTVA.US](https://longbridge.com/en/quote/MTVA.US.md) - [INM.US](https://longbridge.com/en/quote/INM.US.md) - [EDSA.US](https://longbridge.com/en/quote/EDSA.US.md) - [CODX.US](https://longbridge.com/en/quote/CODX.US.md) - [AIM.US](https://longbridge.com/en/quote/AIM.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [ADIL.US](https://longbridge.com/en/quote/ADIL.US.md) - [VRAX.US](https://longbridge.com/en/quote/VRAX.US.md) - [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md) - [PBM.US](https://longbridge.com/en/quote/PBM.US.md) - [QUCY.US](https://longbridge.com/en/quote/QUCY.US.md) - [AIMID.US](https://longbridge.com/en/quote/AIMID.US.md) - [AIMI.US](https://longbridge.com/en/quote/AIMI.US.md) - [PBMWW.US](https://longbridge.com/en/quote/PBMWW.US.md) - [MYNZ.US](https://longbridge.com/en/quote/MYNZ.US.md) ## Related News & Research - [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md) - [Co-Diagnostics Q1 revenue rises but net loss widens](https://longbridge.com/en/news/286460572.md) - [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md) - [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md) - [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)